These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 31494202)
1. Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay. Zhou H; Peng X; Hou T; Zhao N; Qiu M; Zhang X; Liang X J Ethnopharmacol; 2020 Jan; 246():112218. PubMed ID: 31494202 [TBL] [Abstract][Full Text] [Related]
2. Label-free cell phenotypic study of opioid receptors and discovery of novel mu opioid ligands from natural products. Hou T; Xu F; Peng X; Zhou H; Zhang X; Qiu M; Wang J; Liu Y; Liang X J Ethnopharmacol; 2021 Apr; 270():113872. PubMed ID: 33485984 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
4. Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors. Yang Y; Vyawahare R; Lewis-Bakker M; Clarke HA; Wong AHC; Kotra LP Molecules; 2020 Jul; 25(15):. PubMed ID: 32751516 [TBL] [Abstract][Full Text] [Related]
5. Development and preliminary validation of a plate-based CB1/CB2 receptor functional assay. Dossou KS; Devkota KP; Kavanagh PV; Beutler JA; Egan JM; Moaddel R Anal Biochem; 2013 Jun; 437(2):138-43. PubMed ID: 23481912 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship. Rao GK; Kaminski NE J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624 [TBL] [Abstract][Full Text] [Related]
9. Cannabichromene is a cannabinoid CB Udoh M; Santiago M; Devenish S; McGregor IS; Connor M Br J Pharmacol; 2019 Dec; 176(23):4537-4547. PubMed ID: 31368508 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
11. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. Glass M; Felder CC J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. Showalter VM; Compton DR; Martin BR; Abood ME J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477 [TBL] [Abstract][Full Text] [Related]
13. Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G Hua T; Li X; Wu L; Iliopoulos-Tsoutsouvas C; Wang Y; Wu M; Shen L; Brust CA; Nikas SP; Song F; Song X; Yuan S; Sun Q; Wu Y; Jiang S; Grim TW; Benchama O; Stahl EL; Zvonok N; Zhao S; Bohn LM; Makriyannis A; Liu ZJ Cell; 2020 Feb; 180(4):655-665.e18. PubMed ID: 32004463 [TBL] [Abstract][Full Text] [Related]
14. Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors. Codd EE; Mabus JR; Murray BS; Zhang SP; Flores CM Assay Drug Dev Technol; 2011 Aug; 9(4):362-72. PubMed ID: 21323580 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195 [TBL] [Abstract][Full Text] [Related]
16. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain. Deng L; Cornett BL; Mackie K; Hohmann AG Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain. Xu JJ; Diaz P; Astruc-Diaz F; Craig S; Munoz E; Naguib M Anesth Analg; 2010 Jul; 111(1):99-109. PubMed ID: 20522703 [TBL] [Abstract][Full Text] [Related]
18. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy. Barnes RC; Blanton H; Dancel CL; Castro-Piedras I; Rorabaugh BR; Morgan DJ; Guindon J J Pharmacol Exp Ther; 2024 Oct; 391(2):258-271. PubMed ID: 38936979 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. Ashton JC; Wright JL; McPartland JM; Tyndall JD Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620 [TBL] [Abstract][Full Text] [Related]
20. Pure Δ Romano B; Pagano E; Orlando P; Capasso R; Cascio MG; Pertwee R; Marzo VD; Izzo AA; Borrelli F Pharmacol Res; 2016 Nov; 113(Pt A):199-208. PubMed ID: 27498155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]